Company intelligence / Profile preview

Paragon Biosciences

Chicago, Illinois, United Statesparagonbiosci.com ↗

Ownership: Private
Employees: ~27
Development stage: Commercial

Overview

Paragon Biosciences is a global life science leader that creates, builds, and funds innovative biology-based companies. The company has a portfolio of independently-run bioscience companies focusing on biopharmaceuticals, AI-enabled life science products, and advanced treatments. One of its portfolio companies, Harmony Biosciences, has successfully commercialized the first nonscheduled treatment for narcolepsy[1][3].

Therapeutic areas: DermatologyOphthalmologyNeurology
Modalities: Gene therapiescell therapiesprotein therapeuticssmall molecules
Industry: Investors

Drug pipeline

1 asset

D-Fi

Phase 3

Indications: Dystrophic epidermolysis bullosa

Partnerships

Blackstone (NYSE: BX)

Beyond the preview

Go deeper on Paragon Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paragon Biosciences.

Explore the full profile